Search Results

You searched for : monoclonal

	Nasal Immunotherapy Shows Promise in Reducing Inflammation and Boosting Cognitive Function in Alzheimer's Disease The discovery of nasal immunotherapy with anti-CD3 as a potential treatment for Alzheimer's disease represents a ray of hope for the millions of ... Sep 15
	Is Omicron Dangerous? Know the real truth In fact, regarding the Omicron variant, doctors believe that the Omicron variant is more dangerous than the Delta variant of the corona. However, it is ... Jan 11
	WuXi Biologics launches a new GMP commercial drug product facility Latest Pharma news updates... Nov 02
	Agomab Therapeutics to acquire Origo Biopharma Latest pharma news update... Oct 29
	Atreca and Bill & Melinda Gates Medical Research Institute to develop a Monoclonal Antibody to cure Malaria Latest pharma news update... Oct 23
	Enzolytics Inc. and Samsung Biologics joins hands for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies Latest news updates... Oct 12
	Boehringer Ingelheim and Invetx collaborates to advance monoclonal antibody biotherapeutics in animal health Latest pharma news update... Sep 29
	WHO recommends antibody treatment for covid patients at high risk of hospital admission And for severely ill patients who have no natural antibodies to covid-19 ... Sep 27
	Tonix Pharmaceutical to develop precision medicine techniques for COVID-19 Vaccines and Therapeutics Latest pharma update... Sep 27
	Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab Latest pharma Update... Sep 06
	ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors Latest Pharma News Update... Aug 31
	Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106 Latest Pharma Update... Aug 23
	GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab Latest pharma news update... Aug 02
	FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3 Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966 ... Jul 30
	FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3 Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966 ... Jul 30
	ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE drug delivery technology Halozymeâ€™s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up ... Jun 22
	GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448 With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
	FDA authorizes monoclonal antibody therapy for emergency use in some patients 12 and older The authorization is specifically for those with mild-to-moderate Covid-19, who are at risk of getting much sicker... May 27
	GSK and Vir Biotechnology starts EMA rolling review of VIR-7831 (sotrovimab) for treatment of COVID-19 GSK's Covid product could be soon in the market after the emergency medical application review... May 11
	Sorrento receives FDA clearance Phase 2 study for Sti-3031 ; Advanced Urothelial Carcinoma Sorrento intends to combine a variety of its proprietary mAbs in conjunction with the ADNAB technology platform... Apr 28
	Samsung Biologics and TG Therapeutics expand collaboration for the large scale manufacture of Ublituximab Pharma Update ; Samsung expands capacity ; Ublituximab ... Apr 26
	Exelixis ; U.S. FDA accepts investigational new drug application for XB002 in patients with Advanced Solid Tumors New drug for treating advanced tumour under investigation... Apr 07
	GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19 The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ... Mar 27
	GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19 The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ... Mar 27
	US government stops distribution of Eli Lilly Covid-19 antibody treatment for Covid-19 The move comes after the detection of different Covid variants ... Mar 26
25 Matching result(s) found!

-Advertisements-

Trending Now
	FLO organized a session with two of the top VCs in India on "The Journey of an Idea"June 06, 2024
	FTCCI organised a Workshop on "Opportunities in Food Processing"June 06, 2024
	Roundtable conference on Ethical Business Practices heldJune 06, 2024
	Magniflex India makes a sustainable leap forward with the launch of MagnigeoJune 06, 2024
	Unlocking the Secrets of Sleep: How Rest Impacts Brain Health and Waste RemovalJune 06, 2024
	ICMR Warns Against Overheating Non-Stick Pans: Tips to Prevent Toxin ExposureJune 06, 2024
	Promising New HIV Vaccine Candidate Shows Early Success: A Hopeful Step in HIV ResearchJune 06, 2024
	MAGGI makes an appeal on World Environment Day: ‘2-Min for the Environment: Everyone. Everyday.’June 05, 2024
	HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver CongressJune 05, 2024
	FSSAI Enforces Transparency: No More '100% Fruit Juice' Claims on Reconstituted ProductsJune 05, 2024
	Is Omega-3 Fatty Acid and Fish Oil Good for Your Heart? Recent Study Suggest Mixed ResultsJune 05, 2024
	Neonatal Unit Fire: Court Dismisses Bail for Unqualified Ayurvedic DoctorJune 05, 2024
	Protect the medicines that protect usJune 04, 2024
	New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for BiotechsJune 04, 2024
	Indonesia is enforcing stronger anti-tobacco measures despite industry interferenceJune 04, 2024
	How will a NDA win in Lok Sabha polls impact healthcare market June 04, 2024
	Strokes Aren’t Just for the Elderly: A 33-Year-Old’s Survival StoryJune 04, 2024
	From Lower Back Pain to Cardiovascular Disease: Addressing the Health Divide Between Men and WomenJune 04, 2024
	Attack on Doctor at GB Hospital Sparks Outrage in Medical CommunityJune 04, 2024
	How Age Discrimination Impacts Indian Employees: A Closer LookJune 04, 2024

Search Results

Nasal Immunotherapy Shows Promise in Reducing Inflammation and Boosting Cognitive Function in Alzheimer's Disease

Is Omicron Dangerous? Know the real truth

WuXi Biologics launches a new GMP commercial drug product facility

Agomab Therapeutics to acquire Origo Biopharma

Atreca and Bill & Melinda Gates Medical Research Institute to develop a Monoclonal Antibody to cure Malaria

Enzolytics Inc. and Samsung Biologics joins hands for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies

Boehringer Ingelheim and Invetx collaborates to advance monoclonal antibody biotherapeutics in animal health

WHO recommends antibody treatment for covid patients at high risk of hospital admission

Tonix Pharmaceutical to develop precision medicine techniques for COVID-19 Vaccines and Therapeutics

Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab

ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106

GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab

FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3

FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3

ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE drug delivery technology

GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448

FDA authorizes monoclonal antibody therapy for emergency use in some patients 12 and older

GSK and Vir Biotechnology starts EMA rolling review of VIR-7831 (sotrovimab) for treatment of COVID-19

Sorrento receives FDA clearance Phase 2 study for Sti-3031 ; Advanced Urothelial Carcinoma

Samsung Biologics and TG Therapeutics expand collaboration for the large scale manufacture of Ublituximab

Exelixis ; U.S. FDA accepts investigational new drug application for XB002 in patients with Advanced Solid Tumors

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

US government stops distribution of Eli Lilly Covid-19 antibody treatment for Covid-19

Trending Now